Deadline: 21 August 2017
The Target Research Platform (TRP), in partnership with the Wellcome Trust is inviting applicants for its Global Health Innovative Technology Fund (GHIT Fund) that will focus on promoting the discovery and development of new health technologies, including drugs, vaccines, and diagnostics for infectious diseases prevalent in developing countries.
The GHIT Fund endeavors to facilitate collaboration and funding of global health technology R&D originating from Japan, to build momentum, and to demonstrate action and results.
The TRP is currently focused on technologies and approaches that address unmet or priority needs within malaria, tuberculosis, HIV/AIDS and any of the Neglected Tropical Diseases recognized by the World Health Organization.
Duration
The duration of the project shall not exceed two years.
Eligibility Criteria
- Proposed projects should be primarily originated from and be led by Japanese organizations and partnerships will need to be between eligible Japanese and non-Japanese organizations.
- The proposed collaboration project may include, but is not limited to:
- Novel mechanisms of action for therapeutic targeting
- Pathogen component targeting to impact disease rather than infection
- Novel vaccine concepts, targets, and constructs
- New and improved approaches to diagnostic assays
How to Apply
Interested applicants must apply online via given website.
For more information, please visit GHIT Fund.